The Lou Ruvo Center for Brain Health offers patients and caregivers a complete continuum of care, infusing education and research into all that we do for those afflicted by neurocognitive disorders.
The Salk Institute consistently ranks among the leading research institutions in the world for its faculty's contributions and the impact of their findings.
The principal goal of CNI is to advance drug testing to allow more treatments to reach patients faster--in particular, clinical trials and new therapy development for central nervous system diseases.
Researchers at Brigham and Women's Hospital are conducting promising new basic and translational research that will address three major unsolved questions about Alzheimer's Disease.
The NIH’s largest public-private partnership on brain research, ADNI tracks normal, mildly cognitively impaired, and Alzheimer's disease brain changes to measure the progression of the condition.